Alterity Therapeutics (ATHE) EBIT Margin (2016 - 2019)
Alterity Therapeutics (ATHE) posted quarterly EBIT Margin of 304.03% for Q4 2019, down 8137.0% year-over-year from 3.78% in Q4 2018, and down 36.54% quarter-over-quarter from 222.66% in Q4 2018.
Alterity Therapeutics (ATHE) EBIT Margin (2016 - 2019) Analysis & Trends
Alterity Therapeutics' EBIT Margin history runs 4 years deep, the most recent figure standing at 304.03% for Q4 2019.
- In Q4 2019, EBIT Margin fell 8137.0% year-over-year to 304.03%; the TTM figure through Dec 2019 stood at 543.24% (up 3607.0% YoY), while the FY2024 annual figure was 419.05%, changed N/A from the prior year.
- EBIT Margin for Q4 2019 stood at 304.03%, down from 222.66% in the prior quarter.
- The five-year high for EBIT Margin was 3178.13% in Q4 2017, with the low at 304.03% in Q4 2019.
- The 4-year median for EBIT Margin is 215.68% (2018), against an average of 610.68%.
- The sharpest annual moves came in 2017 and 2018: EBIT Margin jumped 338683 bps in 2017, then sank 340079 bps in 2018.
- Alterity Therapeutics' EBIT Margin stood at 208.71% in 2016, then surged by 1623 bps to 3178.13% in 2017, then sank by 107 bps to 222.66% in 2018, then slumped by 37 bps to 304.03% in 2019.
- Business Quant data shows ATHE's EBIT Margin at 304.03% in Q4 2019, 222.66% in Q4 2018, and 3178.13% in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 17.93% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -35.57% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.36% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.75% |
| 10 | Alterity Therapeutics | 48.56 Mn | 16.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -304.03% |
| Dec 31, 2018 | -222.66% |
| Dec 31, 2017 | 3,178.13% |
| Dec 31, 2016 | -208.71% |